Media centerClara Prieto2024-03-04T17:33:54+01:00

MEDIA CENTER

Keep up to date with our latest news and resources

PRESS RELEASES

Catch up with the latest updates from our company

mAbxience and Biosidus Sign CDMO Agreement for the Manufacture of Agalsidase Beta for the Treatment of Fabry Disease

Miguel Martínez-Cava2024-02-05T11:58:27+01:00February 5, 2024|Press releases|

mAbxience Announces Licensing Agreement with Intas Pharmaceuticals Ltd. for Etanercept Biosimilar Targeting Autoimmune Diseases in more than 150 Countries, including Europe and the United States of America

Miguel Martínez-Cava2023-12-20T10:49:24+01:00December 20, 2023|Press releases|

mAbxience and Abdi İbrahim Announce Landmark Technology Transfer Agreement, Advancing Biotechnology in Türkiye

Miguel Martínez-Cava2023-11-20T08:43:23+01:00November 20, 2023|Press releases|

BLOG

Dive into the insights from mAbxience, written by our team

Discover the hidden opportunities: real stories of growth at mAbxience

Clara Prieto2024-08-14T12:28:54+02:00August 14, 2024|News|

Mastering biopharma: expert know-how, single-use systems and adaptable manufacturing

Clara Prieto2024-07-31T16:52:12+02:00July 31, 2024|News|

From cell to bench and beyond: the manufacturing journey inside mAbxience

Clara Prieto2024-07-08T15:31:54+02:00July 8, 2024|News|

MULTIMEDIA

Browse our media resources and materials

mAbxience | INFOGRAPHIC

Similarity Exercise | VIDEO

mAbxience Biosimilar Development | VIDEO

mAbxience León site | VIDEO

mAbxience Argentina | VIDEO

mAbxience | VIDEO